Jennifer Pietenpol
-
Gene ‘signature’ may predict cancer outcomes
A gene signature may be useful in predicting outcomes for patients with rhabdomysarcoma, a form of cancer most commonly diagnosed in children. Read MoreMar 25, 2011
-
President names Jennifer Pietenpol to National Cancer Advisory Board
President George W. Bush has appointed Jennifer A. Pietenpol, director of Vanderbilt-Ingram Cancer Center, to the National Cancer Advisory Board. Pietenpol, the B.F. Byrd Jr. Professor of Oncology at Vanderbilt-Ingram, will serve a six-year term through March 9, 2014. Read MoreJun 16, 2008
-
Pietenpol Chosen to Lead Vanderbilt-Ingram Cancer Center
Jennifer Pietenpol, Ph.D., Ingram Professor of Cancer Research and professor of Biochemistry, has been named director of Vanderbilt-Ingram Cancer Center. Read MoreJan 17, 2008